Skip to main content
List

Tests in pain conditions (focusing on malignant tumors)

2026-08-04

Musculoskeletal patients complaining of pain: tests to differentiate malignant tumors

Hello. I am Dr. Wonsik Ahn, director of ANSim Pain Clinic.

For musculoskeletal patients complaining of pain, I will explain, with a focus on tests to differentiate malignant tumors.

Summarized with a focus on the tests, in musculoskeletal pain, to rule out or confirm the possibility of a "malignant tumor", the key is to combine in an orderly sequence tests that look at structural abnormalities of the painful area itself, tests that look for systemic staging/the primary lesion, and a biopsy for final confirmation.

Therefore, for each test, what is checked and, based on the results, ​which diagnostic possibilities are weighed are summarized as follows.

What is checked on plain X-ray (plain radiography) and what it means

Plain X-ray is the basic test used first in musculoskeletal pain; it quickly checks for "changes in bone shape" to screen for the possibility of malignant disease.

When a malignant bone lesion is suspected, we first check for focal bone destruction (lytic lesions) or abnormal bone formation (sclerotic lesions) to assess the possibility of a neoplastic lesion.

​In addition, destruction of cortical bone and the presence of pathologic fractures are checked to determine whether the cause of the pain is not a simple sprain or degenerative change but is based on structural weakness.

In particular, when a primary malignant bone tumor is suspected, findings such as periosteal reaction (e.g., lamellar/spiculated reaction), a mass extending outside the bone, and tumor calcification are checked to gauge whether the lesion is aggressive.

​However, early bone marrow involvement or soft tissue involvement can be missed on X-ray, so even if there is no clear abnormality on X-ray, if the pain pattern is atypical (night pain, pain at rest, progressive pain, etc.), one should proceed to the next imaging test.

ANSim Pain Clinic - X-ray room-1.png

What is checked on ultrasound and what it means

Ultrasound is well suited to evaluating “soft tissue (muscles, tendons, fascia, subcutaneous tissue)” and “superficial masses”, and it is especially valuable when a lump (mass) can be felt at the painful site or local swelling is present, as a first-line screening test.

​When assessing the possibility of a malignant soft tissue tumor, ultrasound is used to check whether it is a solid mass or a cystic lesion, and whether the margins are irregular/appear infiltrative.

In addition, Doppler is used to check for increased blood flow inside and around the mass, making it possible to estimate neoplastic vascular (or inflammatory) changes.

When nerve-related pain is suspected, scanning along the course of the nerve and observing whether there is a mass continuous with the nerve, or whether the nerve is compressed or deformed provides clues for considering the possibility of a peripheral nerve sheath tumor.

​However, ultrasound alone cannot determine whether a lesion is malignant or benign, and it has limits in assessing deep masses or extent, so if there are suspicious findings, detailed evaluation with MRI is needed.

ANSim Pain Clinic - ultrasound room.png

What is checked on CT and what it means

CT is useful when plain X-ray is equivocal or a more detailed evaluation of bone structure is needed, because it shows the cortical bone and calcified structures of bone in detail.

​When a malignant bone lesion is suspected, CT more clearly shows the extent of cortical bone destruction, the distribution of osteolysis/sclerosis, and patterns of tumor calcification or chondroid calcification, allowing the nature of the lesion to be estimated.

In addition, when a pathologic fracture is suspected, CT helps determine the shape and stability of the fracture.

In terms of systemic evaluation, to check common sites of metastasis in malignant tumors, checking for lung metastasis with chest CT is often included.

What is checked on MRI and what it means

MRI is the key test for determining "extent and infiltration" in the evaluation of malignant tumors; in particular, it can most sensitively detect bone marrow involvement and soft tissue involvement.

​When a malignant bone tumor is suspected, MRI checks the length and extent of the lesion within the bone marrow, whether a soft tissue mass has formed, whether the joint is involved, and the relationship with the neurovascular bundles, providing the information needed for surgical and treatment planning.

When a malignant lesion is suspected in spinal pain, MRI is used to check for spinal cord/nerve root compression, epidural masses, and vertebral body infiltration to determine whether the situation requires emergency decompression.

In soft tissue tumors as well, MRI comprehensively evaluates infiltration beyond the fascia, internal necrosis/hemorrhage, invasion of surrounding structures, and so on, and is important for finding findings that raise the likelihood of malignancy. When contrast enhancement is also performed, it helps identify the vascularity and active areas of the mass.

What is checked on a bone scan (bone scintigraphy) and what it means

A bone scan can evaluate bone metabolic activity throughout the body at once, so it is widely used to screen for multiple bone lesions or bone metastases​. When bone metastasis is suspected, the bone scan is used to check whether there are foci of increased uptake appearing in several sites at the same time to assess the possibility of metastasis.

However, increased uptake on a bone scan can also appear with fractures, degenerative changes, inflammation, and the like, so if a site of abnormal uptake is found, additional confirmation of that site with CT/MRI or X-ray is needed.

What is checked on PET-CT and what it means

PET-CT can search the whole body for metabolically active lesions​, making it useful for finding the primary lesion and for staging. When a malignant tumor is suspected, or staging is needed after it has already been diagnosed, PET-CT is used to check the distribution of hypermetabolic lesions throughout the body to assess whether there is metastasis, and when the primary site is unclear, it helps find hypermetabolic foci suspected to be the primary site.

​In addition, after treatment, it can be used to track the metabolic activity of residual/recurrent lesions. However, not all tumors are well visualized on PET, and inflammatory lesions can also appear hypermetabolic, so results must be interpreted together with clinical and other imaging findings.

What is checked in blood tests and what it means

Blood tests are, to be safe, best understood not as tests that confirm a malignant tumor on their own, but as a means of grasping the overall condition and providing clues that strongly suggest particular groups of diseases: a “supplementary assessment”.

When malignant disease is suspected, a CBC is used to check for anemia and white blood cell/platelet abnormalities, confirming bone marrow involvement or a pattern of chronic disease.

In biochemical tests, calcium and creatinine are checked to assess whether hypercalcemia or decreased kidney function, which are common in multiple myeloma, are present, and ALP is used to indirectly estimate situations in which bone formation/destruction is increased.

ESR/CRP are indicators of inflammatory response, but because they can also rise in malignant disease, they are used as a reference as a "nonspecific warning sign."

When a specific cancer is strongly suspected, PSA, CEA, and the like ​tumor markers can be checked to support the direction of diagnosis, but because tumor markers have false positives/false negatives, it must be understood that they are not used as the sole basis for diagnosis. When multiple myeloma is suspected, it is important to perform SPEP/UPEP, immunofixation, and free light chain testing to confirm the presence of monoclonal protein.

What is checked in nerve conduction studies/electromyography (NCS/EMG) and what it means

Nerve conduction studies and electromyography are functional tests that check "nerve function", and are used to objectively determine the location and severity of the lesion when the pain has a neuropathic pattern (numbness, decreased sensation, decreased muscle strength, radiating pain, etc.).

When a malignant tumor is suspected of compressing or invading a nerve, NCS/EMG are used to check which peripheral nerve or nerve root segment is damaged, and whether there is a demyelinating/axonal pattern of injury, to assess the functional impact of the lesion.

However, these tests are not "tests that directly show the cause (the tumor itself)" but "tests that prove decreased nerve function," so imaging tests such as MRI take priority for confirming the presence and extent of a tumor, and NCS/EMG are generally placed in a supportive role.

ANSim Pain Clinic - EMG room.png

Biopsy for final confirmation

If imaging tests and clinical findings raise the likelihood of malignancy, the pathological diagnosis must ultimately be confirmed through a biopsy.

At this stage, image guidance such as ultrasound or CT is used to perform a biopsy precisely targeting the active lesion, and the treatment strategy is decided after confirming the histologic type and grade of malignancy. In particular, for bone and soft tissue tumors, the biopsy route can affect the extent of future surgery, so whenever possible it is safest to perform the biopsy under the plan of the team that will be responsible for treating the tumor.


In summary, plain X-ray quickly screens for "aggressive changes in bone," ultrasound provides a first-line evaluation of "soft tissue masses and blood flow," CT precisely confirms "cortical bone, calcification, and lung metastasis," and MRI definitively evaluates "the extent of infiltration and compression of nerves, blood vessels, and the spinal cord." Bone scans and PET-CT are whole-body evaluation tools that confirm "systemic distribution and stage," blood tests and nerve conduction studies/electromyography provide supportive confirmation of "systemic clues" and "functional impairment," respectively, and the final diagnosis is completed with a biopsy.